Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

30 Jan 2023Rheumatology

Connie TANG

This content is sponsored. It is intended for healthcare professionals only.

During an industry-sponsored symposium at the recent 24th Asia-Pacific League of Associations for Rheumatology (APLAR) Congress, Dr Ho So of The Chinese University of Hong Kong evaluated up-to-date evidence on the effectiveness and safety of coronavirus disease (COVID-19) vaccines in patients with autoimmune rheumatic diseases (ARDs).

INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.